Ligand validation:3PGJ

SKM: (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX-1-ENE-1-CARBOXYLIC ACID

SKM is a Ligand Of Interest in 3PGJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PGJ_SKM_B_279	49%	52%	0.206	0.956	0.74	1.11	-	2	0	0	100%	1
3PGJ_SKM_A_279	48%	59%	0.2	0.945	0.78	0.76	-	-	0	0	100%	1
3PGJ_SKM_C_279	43%	57%	0.234	0.96	0.81	0.83	-	-	0	0	100%	1
3PGJ_SKM_D_279	27%	59%	0.289	0.937	0.8	0.76	1	-	1	0	100%	1
3SEF_SKM_C_279	10%	52%	0.364	0.872	0.76	1.11	-	1	0	0	100%	0.9
2AA9_SKM_A_501	99%	29%	0.047	0.982	1.79	1.18	2	2	0	0	100%	1
3NVS_SKM_A_428	98%	12%	0.061	0.984	2.58	1.66	1	3	4	0	100%	0.4
2AAY_SKM_A_701	95%	32%	0.063	0.967	1.66	1.14	2	2	0	0	100%	1
3TNL_SKM_A_293	95%	49%	0.065	0.967	0.83	1.15	-	1	0	0	100%	1
5TED_SKM_A_401	93%	1%	0.08	0.977	8.37	1.09	6	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.